Revenue | ₹0.93Cr |
Net Profits | ₹0.08Cr |
Net Profit Margins | 8.60% |
Biofil Chemicals & Pharmaceuticals Ltd’s revenue fell -93.46% since last year same period to ₹0.93Cr in the Q3 2025-2026. On a quarterly growth basis, Biofil Chemicals & Pharmaceuticals Ltd has generated -93.16% fall in its revenue since last 3-months.
Biofil Chemicals & Pharmaceuticals Ltd’s net profit fell -50% since last year same period to ₹0.08Cr in the Q3 2025-2026. On a quarterly growth basis, Biofil Chemicals & Pharmaceuticals Ltd has generated 0% jump in its net profits since last 3-months.
Biofil Chemicals & Pharmaceuticals Ltd’s net profit margin jumped 664.52% since last year same period to 8.60% in the Q3 2025-2026. On a quarterly growth basis, Biofil Chemicals & Pharmaceuticals Ltd has generated 1362.37% jumped in its net profit margins since last 3-months.
The revenue for Biofil Chemicals & Pharmaceuticals Ltd in the Q3 results 2025 was ₹0.93Cr.
The net profit for Biofil Chemicals & Pharmaceuticals Ltd in the Q3 results 2025 was ₹0.08Cr.
The net profit margin for Biofil Chemicals & Pharmaceuticals Ltd in the Q3 results 2025 was 8.60%.
The revenue for Biofil Chemicals & Pharmaceuticals Ltd in the Q3 results 2024 was ₹14.22Cr.
The net profit for Biofil Chemicals & Pharmaceuticals Ltd in the Q3 results 2024 was ₹0.16Cr.
The net profit margin for Biofil Chemicals & Pharmaceuticals Ltd in the Q3 results 2024 was 1.13%.